Kathy V. Turner - Feb 18, 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Senior Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Kathy V. Turner
Stock symbol
IDXX
Transactions as of
Feb 18, 2022
Transactions value $
$199,981
Form type
4
Date filed
2/22/2022, 04:01 PM
Previous filing
Feb 16, 2022
Next filing
Nov 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $100K +1.47K +31.32% $67.85* 6.18K Feb 18, 2022 Direct
transaction IDXX Common Stock Options Exercise $100K +706 +11.42% $141.60 6.89K Feb 18, 2022 Direct
holding IDXX Common Stock 100 Feb 18, 2022 by spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1.47K -100% 0 Feb 18, 2022 Common Stock 1.47K $67.85 Direct F2, F4
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -706 -100% 0 Feb 18, 2022 Common Stock 706 $141.60 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2021.
F3 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2022.
F4 Not applicable.